CNCR Stock: Loncar Cancer Immunotherapy ETF Stock Price, Analysis & Insights
Get live CNCR stock price $9.02, comprehensive Loncar Cancer Immunotherapy ETF stock analysis, charts, news, and expert forecast. Real-time CNCR stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
This exchange-traded fund tracks an index primarily consisting of common stock from roughly 30 pharmaceutical or biotechnology companies. These firms are handpicked by the index provider due to their strong emphasis on creating innovative drugs that ...
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Financial Services sector with established market position
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Loncar Cancer Immunotherapy ETF shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Financial Services may affect company performance
- ⚠Past performance does not guarantee future results for Loncar Cancer Immunotherapy ETF
- ⚠Investors should consider how Loncar Cancer Immunotherapy ETF fits within their overall portfolio allocation
Market Cap
7.04M
Beta
0.96
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare CNCR with peer companies:
- Price
- $19.93+0.00% (1D)
- Market cap
- 6.93M
- Price
- $23.44+0.00% (1D)
- Market cap
- 6.91M
- Price
- $56.50+0.00% (1D)
- Market cap
- 6.80M
- Price
- $32.00+0.00% (1D)
- Market cap
- 6.75M
- Price
- $28.55+0.00% (1D)
- Market cap
- 7.14M
- Price
- $26.84+0.00% (1D)
- Market cap
- 7.00M
- Price
- $30.09+0.00% (1D)
- Market cap
- 7.19M
- Price
- $27.46+0.00% (1D)
- Market cap
- 7.03M
- Price
- $47.02+0.00% (1D)
- Market cap
- 7.12M
- Price
- $44.16+0.00% (1D)
- Market cap
- 6.84M
About Financial Services Sector
The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.
Financial Services (1D)
69/100 ⭐⭐⭐⭐
- Overall
- +0.4%
- NYSE
- +0.5%
- NASDAQ
- +0.4%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Industrials | +3.1% | +2.4% | +6.2% | 43.2 | 80/100⭐⭐⭐⭐⭐ |
| Technology | +3.3% | +3.6% | +5.6% | 51.3 | 77/100⭐⭐⭐⭐⭐ |
| Financial Services | +0.4% | +1.4% | +2.0% | 19.6 | 69/100⭐⭐⭐⭐ |
| Basic Materials | +1.8% | +1.2% | +2.9% | 27.4 | 68/100⭐⭐⭐⭐ |
| Healthcare | +1.3% | +0.3% | +3.9% | 30.6 | 67/100⭐⭐⭐⭐ |
| Consumer Cyclical | +1.8% | +2.4% | +1.9% | 54.8 | 51/100⭐⭐⭐ |
| Communication Services | +0.1% | -0.4% | +1.2% | 22.0 | 47/100⭐⭐⭐ |
| Consumer Defensive | -0.7% | +0.2% | -3.8% | 31.0 | 25/100⭐⭐ |
| Real Estate | -0.2% | -1.9% | -0.8% | 49.5 | 25/100⭐⭐ |
| Utilities | +0.9% | -2.4% | -6.2% | 25.8 | 22/100⭐ |
| Energy | -1.6% | -5.6% | -2.1% | 36.1 | 18/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-06-12.